🔗 Share this article

Treasury head Rachel Reeves has announced she is preparing "targeted measures to tackle cost of living pressures" in the upcoming Budget.

In comments to media outlets, she emphasized that lowering price rises is a shared responsibility of both the administration and the central bank.

The United Kingdom's price growth is projected to be the most elevated among the Group of Seven industrialized countries this calendar year and the following year.

Potential Energy Cost Interventions

Reports indicate the administration could take action to bring down energy bills, for example by slashing the present 5% rate of value-added tax applied on energy supplies.

A further possibility is to cut some of the policy costs presently added to bills.

Fiscal Limitations and Expert Predictions

The administration will receive the latest report from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much scope there is for these actions.

The expectation from most analysts is that Reeves will have to announce higher taxes or spending cuts in order to adhere to her self-imposed borrowing rules.

Previously on Thursday, calculations indicated there was a twenty-two billion pound shortfall for the Treasury chief to fill, which is at the more modest range of projections.

"It is a joint task between the central bank and the government to bear down further on some of the sources of inflation," Reeves informed reporters in Washington, at the annual meetings of the IMF and global financial institution.

Revenue Commitments and Global Issues

While a great deal of the focus has been on expected tax rises, the chancellor said the most recent data from the fiscal watchdog had not changed her commitment to election pledges not to increase tax levels on income tax, VAT or National Insurance.

She attributed an "uncertain world" with rising international and commercial tensions for the Budget tax moves, probably to be directed on those "wealthiest."

Global Economic Disputes

Addressing worries about the UK's trade ties with China she said: "The UK's security interests invariably take priority."

Recent announcement by Chinese authorities to tighten export controls on critical minerals and other resources that are essential for high-technology production led American leader Donald Trump to suggest an additional 100% import tax on goods from the Asian country, increasing the possibility of an all-out trade war between the two largest economies.

The US Treasury Secretary called the Chinese decision "economic coercion" and "a global supply chain control attempt."

Inquired about considering the US offer to join its dispute with the Asian nation, the Chancellor said she was "extremely troubled" by China's actions and called on the Beijing authorities "to avoid restrictions and restrict access."

She said the action was "damaging for the international commerce and causes additional challenges."

"In my view there are fields where we must address Chinese policies, but there are also valuable chances to sell into China's economy, including financial services and other sectors of the economic system. We've got to maintain that balance correct."

The Treasury chief also stated she was working with international partners "regarding our own essential resources strategy, so that we are less reliant."

NHS Medicine Pricing and Investment

The Chancellor also acknowledged that the cost the NHS pays for pharmaceuticals could increase as a result of ongoing discussions with the Trump administration and its drugs companies, in exchange for reduced taxes and investment.

A number of the biggest global pharmaceutical manufacturers have said lately that they are either delaying or scrapping operations in the United Kingdom, with some blaming the insufficient payments they are obtaining.

Last month, the Science Minister said the cost the NHS spends on medicines would need to increase to stop firms and pharmaceutical investment departing from the United Kingdom.

Reeves told media: "We have seen because of the cost structure, that drug testing, innovative medicines have not been available in the United Kingdom in the way that they are in other continental states."

"We want to make sure that patients getting care from the National Health Service are able to obtain the best critical treatments in the globe. And so we are reviewing this situation, and... looking to obtain more funding into Britain."